Clinical trials
Heart Failure trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
114 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 8 |
| 2014 | 7 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 5 |
| 2023 | 8 |
| 2024 | 7 |
| 2025 | 14 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Recruiting | 35 |
| Unknown status | 14 |
| Terminated | 12 |
| Active, not recruiting | 5 |
| Not yet recruiting | 4 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yonsei University | 11 |
| Bayer | 8 |
| AstraZeneca | 7 |
| Novartis Pharmaceuticals | 6 |
| Novo Nordisk A/S | 6 |
| Samsung Medical Center | 6 |
| Boehringer Ingelheim | 5 |
| Chong Kun Dang Pharmaceutical | 4 |
| Abbott Medical Devices | 3 |
| Asan Medical Center | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 114 |
| Atrial Fibrillation | 7 |
| Diabetes Mellitus, Type 2 | 7 |
| Ventricular Dysfunction, Left | 7 |
| Hypertension | 6 |
| Renal Insufficiency, Chronic | 6 |
| Cardiovascular Diseases | 5 |
| Coronary Artery Disease | 4 |
| Myocardial Infarction | 4 |
| Acute Coronary Syndrome | 3 |
Trials
Showing 1 to 25 of 114. Each trial links to its page on Pharma Observatory.
14 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.